While the WHO last week recommended that antiviral remdesivir not be used for severely ill Covid-19 patients, Mumbai doctors published the ...

If successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...

Favipiravir, a drug used in the treatment of Covid-19 patients with mild symptoms, became the largest-selling medicine in India in Septembe...

"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...

Avifavir will be delivered to Argentina, Bulgaria, Brazil, Chile, Colombia, Ecuador, El Salvador, Honduras, Kuwait, Panama, Paraguay, Saudi...

Ipca’s export formulations business grew by 89 per cent to 1,500 crore. Sales of HCQ for the quarter totalled Rs 200 crore. The share price...

The Hyderabad-based producer of active pharmaceutical ingredients (APIs) had in May commercialised the Favipiravir API and is currently dis...

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filin...

An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatme...

Results from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with 28.6 per cent faster viral clearance in...

On Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...

However, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...

"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...

Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group on Friday announced the start of the final stage o...

Six leading medical centers in Moscow, Smolensk and Nizhny Novgorod are currently participating in clinical trials, including I.M. Sechenov...

Strides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...

Favipiravir, an off-patent drug originally owned by Japanese drug maker Fuji, holds potential against RNA viruses, one of which is Covid-19...